Skip to main content
Back to Current Affairs
PolitySource: Press Information Bureau

Union Health Ministry Launches SHRESTH – State Health Regulatory Excellence Index, a first-of-its-kind national initiative to benchmark and strengthen state drug regulatory systems through a transparent, data-driven framework

Saturday, 16 August 2025
Read Original Article

Key Points

Union Health Ministry Launches SHRESTH – a groundbreaking initiative designed to benchmark and enhance state drug regulatory systems in India. This matters for UPSC aspirants as it connects to GS Paper 2, focusing on governance and policy implementation. Last Updated: 2025-08-16

Key Facts About SHRESTH

  • State Classification: Categorizes states into Manufacturing States and Primarily Distribution States/UTs.
  • Assessment Criteria: Evaluates states on human resources, lab testing capacity, licensing, surveillance, and public grievance responsiveness.
  • Monitoring and Accountability: States submit monthly data to CDSCO for index scoring.
  • Global Standards: Aligns with WHO’s Global Benchmarking Tool Maturity Level 3.
  • Importance: Ensures consistent drug safety and quality standards.
  • Cooperative Action: Emphasizes collaboration between the center and states for effective pharmaceutical regulation.
  • Capacity-Building Workshops: Plans for more initiatives to strengthen state regulatory processes.
  • NSQ Dashboard: Extension to all states to monitor drug quality.

India's Pharmaceutical Regulatory Enhancement

The SHRESTH initiative holds macro-level significance as it aims to elevate India's pharmaceutical regulatory framework to global standards. By aligning with WHO’s Global Benchmarking Tool, India seeks to bolster its position in the global pharmaceutical market, ensuring drug safety and quality. This initiative supports India's strategic goal of becoming a leading pharmaceutical hub, contributing to economic growth and public health.

Related Government Schemes/Policies

  • Pharmaceuticals and Medical Devices Policy: Aims to promote indigenous production and ensure quality control.
  • Make in India: Encourages domestic manufacturing, including pharmaceuticals.
  • Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP): Provides quality medicines at affordable prices.

UPSC Relevance

  • GS Paper 2: Governance, policies, and interventions for development in various sectors.
  • Prelims Angle: Questions on SHRESTH’s objectives, assessment criteria, and alignment with global standards.
  • Mains Angle: Analytical themes on drug regulation, public health policy, and center-state collaboration.
  • Essay Paper: Topics on health governance and regulatory frameworks.

FAQ Section

  • What is SHRESTH? SHRESTH is the State Health Regulatory Excellence Index launched by the Union Health Ministry to benchmark and enhance state drug regulatory systems through a transparent, data-driven framework.
  • Why is SHRESTH important? SHRESTH is crucial for ensuring consistent drug safety and quality standards across India, aligning with WHO’s global benchmarks and fostering collaboration between the center and states.
  • What are the key features of SHRESTH? Key features include state classification, assessment criteria, monitoring and accountability, alignment with global standards, and a focus on cooperative action and capacity-building workshops.

Detailed Coverage

  • State Classification: Categorizes states into Manufacturing States and Primarily Distribution States/UTs.
  • Assessment Criteria: Evaluates states on human resources, lab testing capacity, licensing, surveillance, and public grievance responsiveness.
  • Monitoring and Accountability: States submit monthly data to CDSCO for index scoring.
  • Global Standards: Aligns with WHO’s Global Benchmarking Tool Maturity Level 3.
  • Importance: Ensures consistent drug safety and quality standards.
  • Cooperative Action: Emphasizes collaboration between the center and states for effective pharmaceutical regulation.
  • Capacity-Building Workshops: Plans for more initiatives to strengthen state regulatory processes.
  • NSQ Dashboard: Extension to all states to monitor drug quality.
  • Symposium: Proposed focus on Drugs Regulatory Systems.
  • Joint Trainings: Expansion of trainings and audits among states.
  • Stakeholder Feedback: Highlights SHRESTH as a tool for harmonizing regulatory processes.
  • Roadmap: SHRESTH serves as a roadmap for safe and effective drugs.
  • Regular Assessments: Aims to regularly assess key parameters for improvement.
  • Commitment to Drug Safety: Pursues drug safety across geographic disparities.
  • Innovation in Technology: Stimulates innovation through harmonized processes.
Polity

Practice Questions

Test your understanding of this article

Question 1 of 50 / 5 answered
1

In the context of the newly launched State Health Regulatory Excellence Index (SHRESTH) by the Union Health Ministry, which of the following assessment criteria is explicitly mentioned as a factor for evaluating state drug regulatory authorities?